May 9, 2024
Grant Mitchell — The Potential of AI Drug Repurposing (EP. 215)
Grant Mitchell is a seasoned entrepreneur, operator, and investor in the areas of health, technology, and machine learning. He is currently the co-founder and CEO of Every Cure, where he uses AI to research rare diseases and conduct drug repurposing....
Grant Mitchell is a seasoned entrepreneur, operator, and investor in the areas of health, technology, and machine learning. He is currently the co-founder and CEO of Every Cure, where he uses AI to research rare diseases and conduct drug repurposing.
Grant joins the show to discuss the use of AI in rare drug research, the role of translational scientists, neglected knowledge, and MUCH MORE!
Important Links:
Show Notes:
- The Organizational Problem in Pharma
- The Power of Biomedical Knowledge Graphs
- The Traditional Pharma Approach to Drug R&D
- Risks in the World of AI-driven Drug Discovery
- The Limits of AI for Medical Use
- Biology’s ‘Ignorome’
- The Role of Translators
- Every Cure’s Typical Supporters
- Neglected Latent Knowledge
- Grant as Emperor of the World
- MORE!
Books/Essays Mentioned:
- The AI Revolution; by Tim Urban (Wait But Why)
- Ikigai - The Japanese Secret to a Long and Happy Life; by Héctor García & Francesc Miralles
Transcript
Listen On
